You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Bim antibody [Y36] (ab32158)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Bim antibody [Y36]
See all Bim products (11) ...

Description

Rabbit monoclonal [Y36] to Bim

Specificity

The antibody can recognize all isoforms of Bim. The antibody does not cross-react with other Bcl-2 family members.

Tested applications

WB, IHC-P, ICC, IPmore details

Cross reactivity

Reacts with

Human

Does not react with

Mouse, Rat

Immunogen

A synthetic peptide corresponding to residues in the exons 2 of human Bim.

Positive control

A431 cell lysate and breast carcinoma tissue.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.01% Sodium Azide
Constituents: 40% Glycerol, 0.05% BSA, 0.15M Sodium chloride, 50mM Tris glycine. pH 7.4

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Monoclonal

Clone number

Y36

Isotype

IgG

  • Western blot - Bim antibody [Y36] (ab32158)Western blot - Bim antibody [Y36] (ab32158) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - Bim antibody [Y36] (ab32158)Immunohistochemistry (Paraffin-embedded sections) - Bim antibody [Y36] (ab32158) image (enlarge)

  • Western blot - Bim antibody [Y36] (ab32158)Western blot - Bim antibody [Y36] (ab32158) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab32158 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ICC: 1/100.
IHC-P: 1/100.
IP: 1/40.
WB: 1/500. Detects a band of approximately 22 kDa (predicted molecular weight: 22 kDa).

Is unsuitable for FACS.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Induces apoptosis. Isoform BimL is more potent than isoform BimEL. Isoform Bim-alpha1, isoform Bim-alpha2 and isoform Bim-alpha3 induce apoptosis, although less potent than the isoforms BimEL, BimL and BimS. Isoform Bim-gamma induces apoptosis.

Tissue specificity

Isoform BimEL, isoform BimL and isoform BimS are the predominant isoforms and are ubiquitously expressed with a tissue-specific variation. Isoform Bim-gamma is most abundantly expressed in small intestine and colon, and in lower levels in spleen, prostate, testis, heart, liver and kidney.

Sequence similarities

Belongs to the Bcl-2 family.

Domain

The BH3 motif is required for Bcl-2 binding and cytotoxicity.

Cellular localization

Mitochondrion and Endomembrane system. Associated with intracytoplasmic membranes.

Target information above from: UniProt accessionO43521 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • BCL2 like 11 antibody
  • Apoptosis facilitator antibody
  • B2L11_HUMAN antibody
  • BAM antibody
  • Bcl 2 interacting mediator of cell death antibody
  • Bcl 2 interacting protein Bim antibody
  • Bcl 2 like protein 11 antibody
  • Bcl 2 related ovarian death agonis antibody
  • Bcl 2 related ovarian death agonist antibody
  • Bcl-2-like protein 11 antibody
  • BCL2 interacting mediator of cell death antibody
  • BCL2 interacting protein Bim antibody
  • BCL2 like 11 (apoptosis facilitator) antibody
  • BCL2 like 11 antibody
  • BCL2 like 11 apoptosis facilitator antibody
  • BCL2 like protein 11 antibody
  • BCL2 related ovarian death agonist antibody
  • Bcl2-interacting mediator of cell death antibody
  • Bcl2-L-11 antibody
  • BCL2L11 antibody
  • BIM alpha3 antibody
  • BIM alpha4 antibody
  • BIM alpha5 antibody
  • BIM alpha6 antibody
  • BIM antibody
  • BIM beta6 antibody
  • BIM beta7 antibody
  • BimEL antibody
  • BimL antibody
  • BOD antibody
see all

Anti-Bim antibody [Y36] images:

  Western blot - Bim antibody [Y36] (ab32158)

Western blot - Bim antibody [Y36] (ab32158)

Anti-Bim antibody [Y36] (ab32158) at 1/500 dilution + A431 cell lysate

Predicted band size : 22 kDa
Observed band size : 22 kDa

  Immunohistochemistry (Paraffin-embedded sections) - Bim antibody [Y36] (ab32158)

Immunohistochemistry (Paraffin-embedded sections) - Bim antibody [Y36] (ab32158)

Immunohistochemical analysis of paraffin-embedded breast carcinoma using ab32158 at 1/100 dilution.

  Western blot - Bim antibody [Y36] (ab32158)

Western blot - Bim antibody [Y36] (ab32158)

Anti-Bim antibody [Y36] (ab32158) at 1/500 dilution + Whole cell lysates prepared from human jurkat cells at 200000 cells

Secondary
HRP conjugated Donkey polyclonal to rabbit IgG at 1/2000 dilution
developed using the ECL technique

Performed under reducing conditions.

Predicted band size : 22 kDa
Observed band size : 22 kDa


Exposure time : 30 seconds

Primary diluted in PBS (5% BSA + 0.1% tween20) and incubated with sample for 1 hour and 30 minutes at 20°C.

The image is a courtesy of an anonymous abreview.

References for Anti-Bim antibody [Y36] (ab32158)

This product has been referenced in:

  • Oussaief Let al. Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent. Virology 387:41-9 (2009). ICC/IF; Human.Read more (PubMed: 19254802) »

See 1 publication for this product

Publishing research using ab32158? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"